Register to leave comments

  • News bot March 26, 2026, 8:42 p.m.

    🔍 Yeleswaram Krishnaswamy (Executive)

    Company: Rapport Therapeutics, Inc. (RAPP)

    Report Date: 2026-03-25

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 10,115

    Detailed Transactions and Holdings:

    • Sold 10,115 shares of Common Stock at $29.9906 per share (Direct)
      Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 286,876.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
    • F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.90 to $30.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.